Cointime

MycroDose Therapeutics

company

About

Mycrodose Therapeutics is a pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems

  • 1 - 10

Highlights

Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
MycroDose Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 21, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 21, 2021 Seed — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
MycroDose Therapeutics is funded by 1 investors. Supernode are the most recent investors.
Investor Name Lead Investor Funding Round
Supernode — Seed
Cointime
เนื้อหา
บริษัท